Funding for this research was provided by:
Fondation pour la Recherche Médicale (FRM/N°DEQ20140329555)
NeuroAtlantic, An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging (EAPA_791/2018-NEUROATLANTIC)
H2020, International Marie Curie Training Network, ENTRAIN, Neuroinflammation (H2020-MSCA-ITN-2018 number 813294)
European Marie Curie International Training Network “NeuroInflammation (FP7)
Received: 23 July 2019
Accepted: 8 September 2019
First Online: 14 October 2019
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures involving animals were in accordance with the ethical standards set by the French ministry of education and research (agreement numbers APAFIS#5115 and APAFIS#4359). The principal investigator (VA, personal license number 14–73) was accredited by the “Direction Départementale des Services Vétérinaires”. The animal investigations were performed under the current European directive (2010/63/EU) as incorporated in national legislation (Decree 87/848) and in authorized laboratories (GIP Cyceron; approval n° E14118001). This article does not contain any study with human participants performed by any of the authors.
: Not applicable.
: The authors declare that they have no competing interests.